Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (SUPN) — Form 25-NSE: SEC filing
About this filing
Supernus Pharmaceuticals, Inc. (SUPN) filed Form 25-NSE (sec filing) with the SEC on Nov 2, 2026.
Key facts
- Document
- —
More SUPN filings
- 8-K
Filed Nov 2, 2026
- S-8 POS
Filed Nov 2, 2026
- S-8 POS
Filed Nov 2, 2026
- S-8 POS
Filed Nov 2, 2026
- S-8 POS
Filed Nov 2, 2026
- S-8 POS
Filed Nov 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.